Delivery Order SPE2DE24D0013-SPE2D625F2Q63
Award Date
3/6/25
Potential Completion Date
3/20/25
Potential Value
$7.5K
Federal Agency
Medical Supply Chain
Awardee
Cepheid
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Sunnyvale, CA 94089, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, was issued by the Defense Logistics Agency (DLA) for the supply of diagnostic testing equipment, reagents, and consumables for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract, valued at $27,200.00, is a firm fixed-price delivery order with no set-aside designation. Cepheid holds several significant federal contract Indefinite Delivery...
This federal contract award, valued at $14,448.00, was issued by the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV) and has no set-aside designation. Cepheid will provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
This federal contract award to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, involves the delivery of diagnostic systems, reagents, and test kits for the detection of infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The $2,910.40 firm fixed-price delivery order was awarded by the Defense Logistics Agency, a component of the U.S. Department of Defense, and has an ultimate completion date of March 14, 2025. The contract does not...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $1,054.20, is a firm fixed-price delivery order contract with no set-aside designation. The contract requires Cepheid to provide the DLA with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. These solutions are used to detect a...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense. The contract, valued at $5,440.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has...
This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract, valued at $2,040.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services to detect infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). This award is not...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $2,244.00, is a firm fixed-price delivery order for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The products are intended to support the detection of infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), and other clinical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $21,080, is a delivery order under the broader DLA Medical Supply Chain program and is not set aside for any specific business category. Cepheid will provide the government with COVID-19, influenza, and respiratory syncytial virus (RSV) test kits, including reagents, consumables, and associated maintenance and support...
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, involves the delivery of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, respiratory syncytial virus (RSV), Methicillin-resistant Staphylococcus aureus (MRSA), and sexually transmitted diseases. The $40,800.00 firm fixed-price delivery order contract was awarded by the Defense Logistics...
This is a federal contract award from the Defense Logistics Agency (DLA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $5,440.00 firm fixed-price delivery order contract is for the provision of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and respiratory syncytial virus (RSV). The contract has no set-aside designation. Cepheid holds several significant...